A report on Jamie Heywood and the ALS (Amyotrophic Lateral Sclerosis) Therapy Development Foundation, which he founded when his younger brother was diagnosed with ALS (also known as Lou Gehrig's Disease). The group, devoted to moving promising ALS research from the lab into human clinical trials, has launched an experimental project which combines ALS research with gene therapy
Performer
Reporter, Charlie Rose
Notes
In English
Title from resource description page (viewed June 13, 2024)